本页面由Tiger Trade Technology Pte. Ltd.提供服务

Theravance Biopharma Inc.

17.03
0.0000
成交量:- -
成交额:- -
市值:8.83亿
市盈率:16.30
高:17.03
开:17.03
低:17.03
收:17.03
52周最高:21.03
52周最低:13.08
股本:5,182.83万
流通股本:2,585.69万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):1.05
每股收益(LYR):2.06
净资产收益率:20.91%
总资产收益率:1.33%
市净率:3.05
市盈率(LYR):8.27

数据加载中...

2024/08/09

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/06/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/03

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/16

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/28

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]